期刊文献+

中青年甲状腺功能亢进患者骨密度特点 被引量:5

Characteristics of bone mineral density in young adult patients with hyperthyroidism
下载PDF
导出
摘要 目的分析中青年甲状腺功能亢进(甲亢)患者骨密度特点及其与病程、病情严重程度的关系。方法使用双能X线骨密度仪分别测定340例中青年甲亢患者及160名年龄匹配的正常对照者的前臂、腰椎及股骨颈骨密度,用化学发光法测定甲亢患者游离三碘甲腺原氨酸(FT3)、游离甲状腺激素(FT4)及促甲状腺激素(TSH),用自动生化仪检测血清钙(Ca)、血清磷(P)、碱性磷酸酶(ALP),比较2组间骨密度及Ca、P、ALP的差异。根据国际临床骨密度学会(ISCD)和国际骨质疏松基金会(IOF)对中青年骨质疏松诊断的不同定义分别将甲亢患者分为骨量正常组(ON1)和骨质疏松组(OP1)、骨量正常组(ON2)、骨量减少组(OD2)、骨质疏松组(OP2),比较使用2种诊断方法得出的骨质疏松检出率,比较各组甲状腺激素(TH)及TSH的差异。结果与正常对照组相比,甲亢患者桡骨全部、腰椎L2-4及股骨颈骨密度均明显降低(均P<0.05)。根据ISCD定义得出的骨质疏松检出率为46.8%,根据IOF定义得出的骨质疏松检出率为27.1%,前臂较腰椎、股骨颈骨密度降低更明显。甲亢患者骨质疏松组较骨量正常组的FT3、FT4明显升高(P<0.05),TSH明显降低(P<0.05)。多元线性回归分析显示桡骨骨密度与FT4、Ca呈负相关,与TSH呈正相关。结论中青年甲亢患者骨质疏松患病率高,骨量丢失较明显的部位为桡骨,过量甲状腺激素及低TSH均可导致骨代谢紊乱。 Objective To investigate the effect of the course and condition of hyperthyroidism on the change of bone mineral density ( BMD) in young adult patients .Methods BMDs at forearm , lumbar vertebrae , and femoral neck were measured using dual-energy X-rays absorptiometry (DEXA) in young adult patients (n=340) and normal subjects (n=60).Free triiodothyronine (FT3), free thyroxine (FT4), and thyroid stimulating hormone (TSH) levels were measured using chemiluminescence method . Alkaline phosphatase ( ALP ) , calcium ( Ca ) , phosphorus ( P ) were measured using automatic biochemical analyzer .ALP, Ca, P, BMD at forearm, lumbar vertebrae and femoral neck were compared between patients amd and normal subjects .According to the different definitions of osteoporosis in the young from International Society for Clinical Densitometry (ISCD) and International Osteoporosis Foundation (IOF), patients were divided into normal group1 (ON1) and osteoporosis group1 (OP1), normal group2 (ON2), Osteopenia group2 (OD2) and osteoporosis group2 (OP2).Compared the incidence of osteoporosis in two different diagnostic criteria .Be-sides, thyroid hormone (TH) and TSH were compared among all groups of patients .Results The BMD at forearm (to-tal radius), lumbar vertebrae 2-4, and femoral neck in the patients were significantly lower than those of normal subjects ( P&lt;0.05 ) .Ca, ALP in the patients were significantly higher than those of normal subjects ( P&lt;0.05 ) .Osteoporosis was found in 46.8%of patients according to definition of ISCD , and in 27.1%of patients according to definition of IOF . Among the three measurement sites , forearm had the highest rate of osteoporosis .. The multiple regression analysis showed that there was an independent negative correlation between BMD of forearm and FT 4, Ca, and an independent positive correlation between BMD of forearm and TSH .Conclusion The rate of osteoporosis in patients with hyperthy-roidism is high and the forearm bone is more obrious .High level of FT3 and FT4 and low level of TSH can cause abnormal bone metabolism .
出处 《中华骨质疏松和骨矿盐疾病杂志》 2014年第1期30-34,共5页 Chinese Journal Of Osteoporosis And Bone Mineral Research
基金 安徽省科技厅年度重点项目(11070403029)
关键词 甲状腺功能亢进 骨密度 骨质疏松 hyperthyroidism bone mineral density osteoporosis
  • 相关文献

参考文献18

  • 1International Society for Clinical Densitometry. 2007 Offi- cial Positions. www. iscd. org. Updated 2010 of the In- ternational Society for Clinical Densitometry [ EB/OL ]. http: //www, ised. org/offieial-positions/, (2013-8-15) (2013-8-30) Accessed November 2012.
  • 2Ferrari S, Bianchi ML, Eisman JA, et al. Osteoporosis in young adults : pathophysiology, diagnosis, and management [J]. Osteoporos Int, 2012, 23:2735-2748.
  • 3Bassett JH, Williams GR. Critical role of the hypothalamic- pituitary-thyroid axis in bone [ J ]. Bone, 2008, 43: 418 -426.
  • 4Udayakumar N, Chandrasekaran M, Rasheed MH, et al. Evaluation of bone mineral density in thyrotoxicosis [ J ]. Singapore Med J, 2006, 47:947 -950.
  • 5Vandeven AC, Erdtsieck RJ. Changes of bone mineral den- sity, quantitative ultrasound parameters and markers of bone turnover during treatment of hyperthyroidism [ J ]. Neth J Med, 2008, 66:428 -432.
  • 6Svare A, Nilsen TI, Bjro T, et al. Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study [Jl. EurJ Endocrinol, 2009, 161:779-786.
  • 7Obermayer-Pietsch B, Dobnig H, Warnkross H, et al. Variable bone mass recovery in hyperthyroid bone disease after radioiodine therapy in postmenopausal patients [ J ]. Maturitas, 2000, 35 : 159 - 166.
  • 8黄灵,李晓牧,凌雁,高鑫.Graves病患者骨质疏松患病情况及骨转换指标特征[J].中华内分泌代谢杂志,2011,27(11):906-910. 被引量:14
  • 9Kanis JA, Delmas P, Burckhardt P, et al. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease [ J]. Osteo- poros Int, 1997, 7 : 390 -406.
  • 10Liu JM, Zhao HY, Ning G, et al. IGF-1 as an early marker for low bone mass or osteoporosis in premenopaus- al and postmenopausal women [ J ]. J Bone Miner Metab, 2008, 26:159-164.

二级参考文献18

  • 1Burge R, Dawson-Hughes B, Solomon DH, et aL Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res, 2007,22:465-475.
  • 2Crepaldi G, Maggi S. Epidemiologic link between osteoporosis and cardiovascular disease. J Endocrinol Invest, 2009,32( Suppl 4) :2-5.
  • 3National Osteoporosis Foundation: The clinician's guide to prevetion and treatment of osteoporosis (2008) . http://wwwnoforg/sites/ default/files/pdfs/NOF_Clincians Guide2OOSpdf 2008.
  • 4Wang Y, Tao Y, Hyman ME, et al. Osteoporosis in China. Osteoporos Int, 2009,20 : 1651-1662.
  • 5Robitaille J, Yoon PW, Moore CA, et al. Prevalence, family history, and prevention of reported osteoporosis in U.S. women. Am J Prey Med, 2008,35:47-54.
  • 6Pinheiro MM, Ciconelli RM, Martini LA, et al. Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian Osteoporosis Study(BRAZOS). Osteoporos Int, 2009,20:399-408.
  • 7Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk a meta-analysis. Thyroid, 2003,13:585-593.
  • 8Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid, 2002,12:411-419.
  • 9Liu G, Peacock M. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Caleif Tissue Int, 1998,62:286-289.
  • 10Tsujimoto M, Chen P, Miyauchi A, et al. PINP as an aid for monitoring patients treated with teriparatide. Bone, 2011,48:798-803.

共引文献13

同被引文献57

  • 1吴艳婷,王颖,徐谦.2型糖尿病合并骨质疏松的研究进展[J].世界最新医学信息文摘,2019,0(76):97-98. 被引量:6
  • 2陈晓燕.高泌乳素血症与骨质疏松[J].国外医学(妇幼保健分册),1996,7(2):49-51. 被引量:2
  • 3Zhang W, Zhang Y, Liu Y, et' al. 'Thyroid-stimulating hormone maintains bone mass and strength by suppressing osteoclast differ- entiation [ J ]. J Biomech,2014,47 ( 6 ) : 1307 -1314.
  • 4Ricken R, Bermpohl F, Schlattmann P, et al. Long-term treatment with supraphysiological doses of thyroid hormone in affective dis- orders-effects on bone mineral density [ J ]. J Affect Disord, 2012, 136(1-2) :e89-e94.
  • 5Combs CE, Nicholls J J, Duncan BJH, et al. Thyroid hormones and bone development[J]. Minerva Endocrinol,2011,36(1 ) :71-85.
  • 6van Rijn LE, Pop VJ, Williams GR. Low bone mineral density is related to high physiological levels of free thyroxine in peri-meno- pausal women [ J]. Eur J Endocrinol,2014,170 ( 3 ) :461-468.
  • 7Onigata K. Thyroid hormone and skeletal metabolism [ J ]. Clin Calcium, 2014,24 ( 6 ) : 821-827.
  • 8Emmanuel AY Dang DA, Hesham FE, et al. Outpatient treatment of children with severe pneumonia with oral amoxicillin In four countries: the MASS study [ J ]. Trop Med Int Health, 2011,16 (8) :1127-1129.
  • 9Shapiro BS, Daneshmand ST, Garner FC, et al. Evidence of im- paired endometrial receptivity after ovarian stimulation for in vitro fertilization:a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders [ J ]. Fertil Steri1,2011,96 (2) :344-348.
  • 10万晓艳,张雪英,冯宝香,王娇,王永强,崔永光,段立宾,王传江.甲状腺机能亢进症对患者骨密度的影响[J].中国地方病防治,2008,23(3):201-202. 被引量:3

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部